Photobilirubin-IXa in the serum of a hyperbilirubinaemic newborn infant was demonstrated for the first time by reversed-phase high-pressure liquid chromatography. The concentrations increased significantly during phototherapy. Corresponding to these changes in the serum, biliary unconjugated bilirubin concentrations increased markedly but photobilirubin-IXa was not detected in the bile. Moreover, large amounts of 'unknown pigment' that are diazo-negative appeared in the bile during phototherapy.
Demonstration of a geometric isomer of bilirubin-IXa in the serum of a hyperbilirubinaemic newborn infant and the mechanism ofjaundice phototherapy Shoju ONISHI, Kenichi ISOBE, Susumu ITOH, Noboru KAWADE and Satoru SUGIYAMA Department ofPediatrics, Nagoya City University Medical School, Kawasumi Mizuho-ku, Nagoya, Japan (Received 6 February 1980) Photobilirubin-IXa in the serum of a hyperbilirubinaemic newborn infant was demonstrated for the first time by reversed-phase high-pressure liquid chromatography. The concentrations increased significantly during phototherapy. Corresponding to these changes in the serum, biliary unconjugated bilirubin concentrations increased markedly but photobilirubin-IXa was not detected in the bile. Moreover, large amounts of 'unknown pigment' that are diazo-negative appeared in the bile during phototherapy.
Phototherapy is an established procedure in neonatal medicine (Seligman, 1977) . Despite its extensive use in newborn infants with hyperbilirubinaemia, the complete mechanism is not known (McDonagh & Ramonas, 1978) . However, it was observed that the considerable amounts of unconjugated bilirubin appear in the bile of Gunn rat (Ostrow, 1971; Ostrow et al., 1974) and newborn infants (Lund & Jacobsen, 1972) after irradiation with blue light and that bilirubin-IXa is normally in the ZZ-configuration at the C-5 and C-15 bridges (Bonnett et al., 1976 (Bonnett et al., , 1978 and undergoes rapid and reversible photoisomerization on irradiation with blue light, giving a photobilirubin with Econfiguration (McDonagh et al., 1979) . The present view of the predominant pathways of removal of bilirubin from the body in the course of phototherapy is photoisomerization (Lightner et al., 1979a,b; Stoll et al., 1979; Onishi et al., 1979a,b) . Chromatography and purification of geometric isomers of naturally occurring bilirubin-IXa have been frustrated by its tendency to revert to (ZZ)-bilirubin-IXa. However, we were able to resolve bilirubin-IXa into its components by h.p.l.c. (Onishi et al., 1979a (Onishi et al., ,b, 1980c . This method was applied to the analysis of biological samples to provide insight into the mechanism of phototherapy and in the present paper we demonstrate the increase of photobilirubin in serum with considerable increases in biliary excretion of (ZZ)-bilirubin-IXa and the appearance of an unknown pigment during phototherapy. A preliminary report of these results has been published previously (Onishi et al., 1979a,b) .
Abbreviation used: h.p.l.c., high-pressure liquid chromatography.
The predominant natural bilirubin isomer, (ZZ)-bilirubin-IXa, will often be abbreviated by the term bilirubin. Mention of the E-configuration refers to any of the photoisomers (EZ, ZE or EE).
Materials and methods H.p.l.c.
Equipment, operation, preparation of calibration curves and peak assignments were as described previously (Onishi et al., 1980c) .
The tests on thermal and catalytic reversion of photobilirubin to (ZZ)-bilirubin-IXa were performed as described previously (Onishi et al., 1980c Bilirubin (E. Merck, Darmstadt, Germany) and tetra-n-butylammonium hydroxide (Wako, Osaka, Japan) were used without further purification. Pentan-2-one (Tokyo Kasei, Tokyo, Japan) was distilled before use. Acetonitrile and all other reagents used were of analytical grade.
Results and discussion
Effect of phototherapy on the serum photobilirubin levels By using reversed-phase h.p.l.c. for photobilirubin analysis as described previously (Onishi et al., 1979a,b) , we analysed the bile pigments in the serum of a hyperbilirubinaemic newborn infant before and during phototherapy. In addition to the large peak of bilirubin with retention time of 116 min, one prominent peak with a retention time of 85 min was observed, indicating that the peak is a more polar bilirubin than bilirubin (Fig. 1) . The fact that photobilirubin is the IXa -isomer was also confirmed by the following observation. Azodipyrroles derived from photobilirubin consisted of equal amounts of endo-and exo-vinyl isomers. This was proved by azopigment analysis on h.p.l.c. as described previously (Onishi et al., 1979a (Onishi et al., , 1980a . The more polar bilirubin peak was collected and kept at 500C for 30min in the dark or with addition of a trace of trifluoroacetic acid (Lightner et al., 1979a) and then analysed again by h.p.l.c. in the same conditions. The peak height of bilirubin was increased, corresponding to the disappearance of the peak at the retention time of the polar bilirubin. A 0 40 80
Retention time (min) photoinduced Z -.E transition in bilirubin has been observed by h.p.l.c. (Onishi et al., 1979a,b; McDonagh et al., 1979) , solvent solubility (Stoll et al., 1979) and difference spectrophotometry (Lightner et al., 1979a,b) . Bilirubin usually exists as an intramolecularly hydrogen-bonded structure, which accounts for its near insolubility in water at physiological pH (Bonnett et al., 1978) . Molecular models show that such extensive hydrogen-bonding is sterically impossible for the three E-configurational isomers (EZ, ZE and EE). Consequently compounds in the E-configuration are more hydrophilic and thermodynamically less stable than Figs. 3(a)-3(b) . The photobilirubin peak was not detected on h.p.l.c. scans. Bilirubin-IXa mono-and di-glucuronide peaks were decreased,' but the peak of unconjugated bilirubin-IX a significantly increased during phototherapy. These peaks were identified by azopigment analysis on h.p.l.c. (Onishi et al., 1979a (Onishi et al., , 1980a . Moreover an 'unknown-pigment' peak, which was diazo-negative, with a retention time of 70min appeared in the bile during phototherapy (Figs. 3a and 3b) . The concentrations of (ZZ)-bilirubin-IXa and of the unknown pigment increased considerably in bile (Fig. 4) , similar but less pronounced changes being found for urine (Fig. 5) . The 'unknown pigment' in the urine on h.p.l.c. may correspond to the 415 nm- Retention time (min) Fig. 3 absorbing substance described previously (Onishi et al., 1969 (Onishi et al., , 1971 . The fact that the existence of photobilirubin is confirmed only in plasma and that, in contrast, only unconjugated bilirubin-IXa is detected in the bile suggests that the E-configuration is preserved during passage from the presumed site of formation near the skin surface, through the plasma and hepatocyte, to excretion in the bile. Moreover, photobilirubin in serum and unconjugated bilirubin in bile have been detected not only in treated infants, but also in all jaundiced babies, so far analysed. In bilirubin metabolism of neonatal jaundice, the excretory pathway through photobilirubin may be physiological. Therefore, the major mechanism of bilirubin metabolism during phototherapy may be anaerobic photoisomerization, as was suggested previously (McDonagh, 1976; Lightner, 1977 
